KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 138 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | +36.4% | 17,700 | +29.2% | 0.00% | +100.0% |
| Q2 2023 | $11 | +10.0% | 13,700 | +7.9% | 0.00% | 0.0% |
| Q1 2023 | $10 | -47.4% | 12,700 | +353.6% | 0.00% | -50.0% |
| Q4 2022 | $19 | -100.0% | 2,800 | -90.0% | 0.00% | -33.3% |
| Q3 2022 | $42,000 | -76.8% | 27,979 | -67.0% | 0.00% | -76.9% |
| Q2 2022 | $181,000 | +2916.7% | 84,869 | +515.0% | 0.01% | – |
| Q1 2022 | $6,000 | -57.1% | 13,800 | +557.1% | 0.00% | -100.0% |
| Q4 2021 | $14,000 | – | 2,100 | +600.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 300 | -62.5% | 0.00% | – |
| Q3 2020 | $1,000 | -80.0% | 800 | -84.3% | 0.00% | – |
| Q2 2020 | $5,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |